Molnupiravir is an investigational oral antiviral being developed for the treatment of COVID-19, and has been submitted for review by the U.S. Food and Drug Administration. Researchers now report that they have engineered enzymes to help manufacture the pill, resulting in a much shorter and higher-yielding synthesis than current methods.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/11/211103140136.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/11/211103140136.htm
A quick, high-yield synthesis of molnupiravir, an investigational COVID antiviral pill
![A quick, high-yield synthesis of molnupiravir, an investigational COVID antiviral pill]()
Reviewed by cmakigo
on
November 04, 2021
Rating:
No comments:
Post a Comment